JP2002532498A5 - - Google Patents

Download PDF

Info

Publication number
JP2002532498A5
JP2002532498A5 JP2000588174A JP2000588174A JP2002532498A5 JP 2002532498 A5 JP2002532498 A5 JP 2002532498A5 JP 2000588174 A JP2000588174 A JP 2000588174A JP 2000588174 A JP2000588174 A JP 2000588174A JP 2002532498 A5 JP2002532498 A5 JP 2002532498A5
Authority
JP
Japan
Prior art keywords
heart
occlusion
experimetria
racemate
chest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000588174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002532498A (ja
Filing date
Publication date
Priority claimed from HU9802897A external-priority patent/HU226617B1/hu
Application filed filed Critical
Publication of JP2002532498A publication Critical patent/JP2002532498A/ja
Publication of JP2002532498A5 publication Critical patent/JP2002532498A5/ja
Withdrawn legal-status Critical Current

Links

JP2000588174A 1998-12-14 1999-12-07 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用 Withdrawn JP2002532498A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9802897A HU226617B1 (en) 1998-12-14 1998-12-14 Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HU9802897 1998-12-14
PCT/HU1999/000095 WO2000035914A1 (en) 1998-12-14 1999-12-07 Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011128516A Division JP5620340B2 (ja) 1998-12-14 2011-06-08 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用

Publications (2)

Publication Number Publication Date
JP2002532498A JP2002532498A (ja) 2002-10-02
JP2002532498A5 true JP2002532498A5 (cg-RX-API-DMAC7.html) 2007-02-08

Family

ID=10991166

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000588174A Withdrawn JP2002532498A (ja) 1998-12-14 1999-12-07 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用
JP2011128516A Expired - Lifetime JP5620340B2 (ja) 1998-12-14 2011-06-08 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011128516A Expired - Lifetime JP5620340B2 (ja) 1998-12-14 2011-06-08 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用

Country Status (27)

Country Link
US (1) US6384029B1 (cg-RX-API-DMAC7.html)
EP (1) EP1147105B1 (cg-RX-API-DMAC7.html)
JP (2) JP2002532498A (cg-RX-API-DMAC7.html)
KR (1) KR100661774B1 (cg-RX-API-DMAC7.html)
AT (1) ATE266027T1 (cg-RX-API-DMAC7.html)
AU (1) AU765336B2 (cg-RX-API-DMAC7.html)
BG (1) BG65179B1 (cg-RX-API-DMAC7.html)
BR (1) BR9913982A (cg-RX-API-DMAC7.html)
CA (1) CA2340734C (cg-RX-API-DMAC7.html)
CZ (1) CZ300764B6 (cg-RX-API-DMAC7.html)
DE (1) DE69917074T2 (cg-RX-API-DMAC7.html)
DK (1) DK1147105T3 (cg-RX-API-DMAC7.html)
EE (1) EE04551B1 (cg-RX-API-DMAC7.html)
ES (1) ES2219091T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20010133B1 (cg-RX-API-DMAC7.html)
HU (1) HU226617B1 (cg-RX-API-DMAC7.html)
IL (1) IL141515A (cg-RX-API-DMAC7.html)
NO (1) NO317649B1 (cg-RX-API-DMAC7.html)
PL (1) PL196584B1 (cg-RX-API-DMAC7.html)
PT (1) PT1147105E (cg-RX-API-DMAC7.html)
RS (1) RS50129B (cg-RX-API-DMAC7.html)
RU (1) RU2222538C2 (cg-RX-API-DMAC7.html)
SI (1) SI1147105T1 (cg-RX-API-DMAC7.html)
SK (1) SK285582B6 (cg-RX-API-DMAC7.html)
UA (1) UA70340C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000035914A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200101182B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057664A1 (en) 2002-01-11 2003-07-17 Biorex Kutató És Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
KR100678577B1 (ko) * 2006-09-11 2007-02-06 조만규 가정용 분전함
JP5616336B2 (ja) 2008-06-26 2014-10-29 オルファザイム エーピーエスOrphazyme Aps 酵素活性の調節因子としてのHsp70の使用
KR20110084514A (ko) 2008-11-18 2011-07-25 산텐 세이야꾸 가부시키가이샤 피리딘-3-카르발데히드 o-(피페리딘-1-일-프로필)-옥심 유도체를 유효 성분으로서 함유하는 망맥락막 변성 질환의 치료제
US9662375B2 (en) 2010-11-30 2017-05-30 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
US10709700B2 (en) 2014-09-15 2020-07-14 Orphazyme A/S Arimoclomol formulation
WO2017178029A1 (en) 2016-04-13 2017-10-19 Orphazyme Aps Heat shock proteins and cholesterol homeostasis
ES2831764T3 (es) 2016-04-29 2021-06-09 Orphazyme As Arimoclomol para el tratamiento de trastornos asociados a glucocerebrosidasa
WO2018215597A1 (en) 2017-05-24 2018-11-29 Orphazyme A/S Heat shock protein inducers and frontotemporal disorders
MX2020012480A (es) 2018-05-28 2021-03-25 Orphazyme As Niveles de la proteina de choque termico 70 (hsp70) en las muestras de celulas mononucleares de la sangre periferica (pbmc) como biomarcador para enfermedades.
EP4247792A1 (en) 2020-11-19 2023-09-27 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT395853B (de) * 1991-01-31 1993-03-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
DE69628320D1 (de) * 1995-11-03 2003-06-26 Summit Packaging Systems Ltd Vorrichtung zum abgeben und füllen von beuteln an einem kassenplatz eines supermarkts
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells

Similar Documents

Publication Publication Date Title
Kantrowitz et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock
JP5620340B2 (ja) 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用
JP2011201916A5 (cg-RX-API-DMAC7.html)
Monge et al. Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino [4, 5-b] indole, 4-hydrazinotriazino [4, 5-a] indole, and related compounds
JP2008501033A (ja) 心停止前、心停止中および心停止後の哺乳動物の治療法
Heller et al. Cardiac complications: results of penetrating chest wounds involving the heart
JPH0248527A (ja) 心筋虚血および/または再潅流中の心筋細胞壊死抑制ならびに心筋機能改善用組成物
Berger et al. The use of diastolic augmentation with the intra-aortic balloon in human septic shock with associated coronary artery disease
Kofidis et al. Antegrade versus retrograde perfusion of the donor lung: impact on the early reperfusion phase
Naito et al. Novel rotational speed modulation system used with venoarterial extracorporeal membrane oxygenation
Bittner et al. Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors
Schäfer et al. Afterload dependent prolongation of left ventricular relaxation: importance of asynchrony
Kurose et al. Emergency and long‐term extracorporeal life support following acute myocardial infarction: Rescue from severe cardiogenic shock related to stunned myocardium
Scholz et al. Protective effect of the hemopump left ventricular assist device in experimental cardiogenic shock
Tod et al. Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid
Weiss et al. Deep hypothermia with total circulatory arrest
CN112209834B (zh) 一种有机亚硝酸根供体及其制备方法与医药用途
JP2003512419A5 (cg-RX-API-DMAC7.html)
RU2086543C1 (ru) Щелочные соли амидов оротовой кислоты и аминокислот, обладающие гипертензивным эффектом
Wilson et al. Perioperative management of calves undergoing implantation of a left ventricular assist device
Payne et al. Perioperative right heart dysfunction
RU2261082C1 (ru) Способ лечения острой дыхательной недостаточности кардиального генеза
Vin-Christian et al. Shock and Pulmonary Edema In an Elderly Woman
Sanchez et al. A Pale Lethargic Girl
Azargoun et al. Comparison of tissue perfusion and electrocardiogram parameters in experimentally induced hemorrhagic shock dogs resuscitated with lactated ringer and hydroxyethyl starch solutions